2016
DOI: 10.21147/j.issn.1000-9604.2016.04.03
|View full text |Cite
|
Sign up to set email alerts
|

DNA image cytometry test for primary screening of esophageal cancer: a population-based multi-center study in high-risk areas in China

Abstract: Objective To evaluate the feasibility of DNA image cytometry (DNA-ICM) as a primary screening method for esophageal squamous cell cancer (ESCC). Methods A total of 5,382 local residents aged 40–69 years from three high-risk areas in China (Linzhou in Henan province, Feicheng in Shandong province and Cixian in Hebei province) from 2008 to 2011 were recruited in this population-based screening study. And 2,526 subjects declined to receive endoscopic biopsy examination with Lugol’s iodine staining, while 9 and 81… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 15 publications
(22 reference statements)
0
11
2
Order By: Relevance
“…Moreover, to make the study completed almost perfectly, researchers and all staff involved also would put more effort to improve the participant rate through some special methods, like increasing communication with high‐risk participants, taking incentives, even contacting their children to persuade them to accept endoscopy, et al So the 29.1% of participation rate in cross‐sectional study over severe years are more authentic and natural. The rate in our study was lower than the participation rate (53.1%) in high‐incidence areas (Linxian in Henan province, Feicheng in Shandong province, and Cixian in Hebei province) 21 . Since 2005, the Chinese government has implemented a series of screening and early detection programs in 11 high‐risk areas.…”
Section: Discussioncontrasting
confidence: 71%
See 1 more Smart Citation
“…Moreover, to make the study completed almost perfectly, researchers and all staff involved also would put more effort to improve the participant rate through some special methods, like increasing communication with high‐risk participants, taking incentives, even contacting their children to persuade them to accept endoscopy, et al So the 29.1% of participation rate in cross‐sectional study over severe years are more authentic and natural. The rate in our study was lower than the participation rate (53.1%) in high‐incidence areas (Linxian in Henan province, Feicheng in Shandong province, and Cixian in Hebei province) 21 . Since 2005, the Chinese government has implemented a series of screening and early detection programs in 11 high‐risk areas.…”
Section: Discussioncontrasting
confidence: 71%
“…The rate in our study was lower than the participation rate (53.1%) in high-incidence areas (Linxian in Henan province, Feicheng in Shandong province, and Cixian in Hebei province). 21 Since 2005, the Chinese government has implemented a series of screening and early detection programs in 11 high-risk areas. Public education campaign on the benefit of endoscopic screening has been ongoing for more than ten years in the high-risk areas while for only several years in the non-high-risk areas.…”
Section: Performance Of the Nomogram In Stratifying Participant Riskmentioning
confidence: 99%
“…There are two main histological types of esophageal cancer, including squamous cell carcinoma and adenocarcinoma ( 2 ). Although, the diagnosis and treatments for esophageal cancer update constantly ( 3 , 4 ), the overall 5-year survival rate is only around 20% ( 5 ). Therefore, it is important and urgent to elucidate an exactly novel molecular mechanism underlying esophageal cancer formation, which may provide new strategies for the diagnosis and treatments of esophageal cancer in future healthcare.…”
Section: Introductionmentioning
confidence: 99%
“…However, the DNA detection method is relatively simple and the training of specialized staff requires a few weeks. LBC diagnoses rely on the judgement of pathologists who require several years of specialized training ( 9 ). However, DNA-ICM can only judge the abnormal cells, but it cannot identify the types of tumor cell, including squamous carcinoma, adenocarcinoma and SCLC.…”
Section: Discussionmentioning
confidence: 99%